Use of a monoclonal antibody anti VEGF (vascular endothelial growth factor) for the treatment of a patient suffering a Relapse of HER2 positive cancer During or after treatment with anTicuerpo anti HER2.

摘要

The present invention provides a method of treating a patient suffering from relapsed HER2 positive cancer with an anti-VEGF antibody during or after treatment with an anti-HER2 antibody. The invention also provides corresponding articles of manufacture.